Bill > HR7559

This bill, the Prescription Information Modernization Act of 2022, aims to provide for the digital communication of prescribing information for drugs (including biological products). The key provisions of the bill are: 1. It amends the Federal Food, Drug, and Cosmetic Act to allow required prescribing information for drugs to be made available solely by electronic means, as long as the manufacturer affords prescribers and dispensers the opportunity to also receive the information in paper form or request paper labeling on an as-needed basis. 2. It requires the Secretary of Health and Human Services to issue final regulations within 1 year to implement this change and provide instructions on how healthcare professionals can receive paper copies of prescribing information from the manufacturer or distributor. 3. It directs the Secretary to design the regulations in a way that minimizes the adverse economic impacts on prescribers and dispensers. 4. It requires the Secretary to hold a public workshop within 2 years to discuss how to continue to optimize the format, accessibility, and usability of prescribing information. 5. It specifies that the amendment will apply to drugs introduced or delivered for introduction into interstate commerce on or after the sooner of 2 years after the bill's enactment or the effective date of the final regulations.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/117th-congress/house-bill/7559/all-info